Skip to content
conflictLOW2026-04-22 15:25 UTC

Sanofi’s new CEO faces a reckoning on immunology-focused R&D strategy

Sanofi CEO Paul Hudson bet big on immunology. When Belén Garijo takes over as CEO next week, she will have to decide whether to continue that wager. The direction Garijo elects to pursue will likely ...

ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD

Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.

GET THE SUNDAY BRIEFING →

RELATED · conflict